Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
School of Health Sciences, University of East Anglia, Norwich, UK.
Emerg Med Australas. 2020 Apr;32(2):190-201. doi: 10.1111/1742-6723.13451. Epub 2020 Feb 23.
To examine trends of ED presentations with a mental health (MH) diagnosis in Australia and its jurisdictions by diagnostic group between 2004-05 and 2016-17.
Data comprised ED presentations with a principal diagnosis of ICD-10-AM F00-F99 (MH ) captured within the National Non-Admitted Patient Emergency Department Care Database. Trends in absolute number and rates of MH presentations per 10 000 population were assessed as differences (x-fold) and annual growth rates (average and compound).
Increased presentation rates were observed for most diagnostic groups, except for mental retardation (F70-F79) and mood disorders (F30-F39). The greatest absolute increase was for psychoactive substance use-related disorders (F10-F19), and relative increase, unspecified mental disorder (F99). There was differentiation across jurisdictions regarding rates of and growth in presentations. In 2016-17, rates at least twice the national average were observed for psychoactive substance-use (F10-F19), schizophrenia and psychotic disorders (F20-F29) and childhood and adolescence onset disorders (F90-F98) in the Northern Territory, F90-F98 in South Australia, personality disorders (F60-F69) in Tasmania and unspecified mental disorder (F99) in New South Wales. The most marked growth was observed for F99 in New South Wales.
Between 2004-05 and 2016-17, rates of ED presentations increased across most MH diagnostic groups, but particularly psychoactive substance use-related disorders. To reduce the need for MH crisis care in Australian EDs, strategies are required to reduce psychoactive substance use in the community, and policies may be needed to strengthen the capability of community MH services and primary care professionals to recognise, diagnose and treat earlier in the course of illness.
通过诊断组别,研究澳大利亚及其司法管辖区 2004-05 年至 2016-17 年期间,以心理健康(MH)诊断为主的急症就诊趋势。
本研究数据来源于国家非住院患者急症护理数据库中,以 ICD-10-AM F00-F99(MH)为主要诊断的急症就诊数据。通过绝对数量和每 10000 人口 MH 就诊率的差异(x 倍)和年增长率(平均和复合)评估 MH 就诊趋势。
除精神发育迟滞(F70-F79)和心境障碍(F30-F39)外,大多数诊断组别的就诊率均有所上升。绝对增幅最大的是与精神活性物质使用相关的障碍(F10-F19),相对增幅最大的是未特指的精神障碍(F99)。各司法管辖区的就诊率和增长率存在差异。2016-17 年,北领地精神活性物质使用障碍(F10-F19)、精神分裂症和精神病性障碍(F20-F29)、儿童和青少年发病障碍(F90-F98)、南澳大利亚州 F90-F98、人格障碍(F60-F69)和新南威尔士州未特指的精神障碍(F99)的就诊率至少是全国平均水平的两倍。新南威尔士州 F99 的增长率最为显著。
2004-05 年至 2016-17 年期间,大多数 MH 诊断组别的急症就诊率均有所上升,尤其是与精神活性物质使用相关的障碍。为减少澳大利亚急症室对 MH 危机护理的需求,需要采取措施减少社区内精神活性物质的使用,可能还需要制定政策,加强社区 MH 服务和初级保健专业人员的能力,以便在疾病早期阶段进行识别、诊断和治疗。